Literature DB >> 27145778

The State of Diabetes Prevention Policy in the USA Following the Affordable Care Act.

Juleigh Nowinski Konchak1, Margaret R Moran2, Matthew J O'Brien2, Namratha R Kandula2,3, Ronald T Ackermann4.   

Abstract

Type 2 diabetes is a major public health problem in the USA, affecting over 12 % of American adults and imposing considerable health and economic burden on individuals and society. There is a strong evidence base demonstrating that lifestyle behavioral changes and some medications can prevent or delay the onset of type 2 diabetes in high risk adults, and several policy and healthcare system changes motivated by the Patient Protection and Affordable Care Act (ACA) have the potential to accelerate diabetes prevention. In this narrative review, we (1) offer a conceptual framework for organizing how the ACA may influence diabetes prevention efforts at the level of individuals, healthcare providers, and health systems; (2) highlight ACA provisions at each of these levels that could accelerate type 2 diabetes prevention nationwide; and (3) explore possible policy gaps and opportunity areas for future research and action.

Entities:  

Keywords:  Affordable Care Act; Diabetes; Health policy; Prediabetes; Primary prevention

Mesh:

Year:  2016        PMID: 27145778      PMCID: PMC5210175          DOI: 10.1007/s11892-016-0742-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  58 in total

1.  Prevention in the United States Affordable Care Act.

Authors:  Charles M Preston; Miriam Alexander
Journal:  J Prev Med Public Health       Date:  2010-11

2.  Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Albert L Siu
Journal:  Ann Intern Med       Date:  2015-10-27       Impact factor: 25.391

Review 3.  Behavioral counseling to promote a healthy lifestyle in persons with cardiovascular risk factors: a systematic review for the U.S. Preventive Services Task Force.

Authors:  Jennifer S Lin; Elizabeth O'Connor; Corinne V Evans; Caitlyn A Senger; Maya G Rowland; Holly C Groom
Journal:  Ann Intern Med       Date:  2014-10-21       Impact factor: 25.391

4.  Association of Pioneer Accountable Care Organizations vs traditional Medicare fee for service with spending, utilization, and patient experience.

Authors:  David J Nyweide; Woolton Lee; Timothy T Cuerdon; Hoangmai H Pham; Megan Cox; Rahul Rajkumar; Patrick H Conway
Journal:  JAMA       Date:  2015-06-02       Impact factor: 56.272

5.  Neighborhoods, obesity, and diabetes--a randomized social experiment.

Authors:  Jens Ludwig; Lisa Sanbonmatsu; Lisa Gennetian; Emma Adam; Greg J Duncan; Lawrence F Katz; Ronald C Kessler; Jeffrey R Kling; Stacy Tessler Lindau; Robert C Whitaker; Thomas W McDade
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

Review 6.  Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.

Authors:  John W Stevens; Kamlesh Khunti; Rebecca Harvey; Maxine Johnson; Louise Preston; Helen Buckley Woods; Melanie Davies; Elizabeth Goyder
Journal:  Diabetes Res Clin Pract       Date:  2015-01-21       Impact factor: 5.602

7.  Research to inform policy in diabetes prevention: a work in progress.

Authors:  Ronald T Ackermann
Journal:  Am J Prev Med       Date:  2012-08       Impact factor: 5.043

8.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

9.  A meta-analysis of interventions to improve care for chronic illnesses.

Authors:  Alexander C Tsai; Sally C Morton; Carol M Mangione; Emmett B Keeler
Journal:  Am J Manag Care       Date:  2005-08       Impact factor: 2.229

10.  The missed patient with diabetes: how access to health care affects the detection of diabetes.

Authors:  Xuanping Zhang; Linda S Geiss; Yiling J Cheng; Gloria L Beckles; Edward W Gregg; Henry S Kahn
Journal:  Diabetes Care       Date:  2008-09       Impact factor: 19.112

View more
  6 in total

1.  Effect on Health Care Expenditures During Nationwide Implementation of the Diabetes Prevention Program as a Health Insurance Benefit.

Authors:  Ronald T Ackermann; Raymond Kang; Andrew J Cooper; David T Liss; Ann M Holmes; Margaret Moran; Chandan Saha
Journal:  Diabetes Care       Date:  2019-04-22       Impact factor: 19.112

Review 2.  Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults.

Authors:  Michael E Bowen; Julie A Schmittdiel; Jeffrey T Kullgren; Ronald T Ackermann; Matthew J O'Brien
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

3.  Screening for Dysglycemia: Connecting Supply and Demand to Slow Growth in Diabetes Incidence.

Authors:  Mohammed K Ali; K M Venkat Narayan
Journal:  PLoS Med       Date:  2016-07-19       Impact factor: 11.069

4.  Non-communicable diseases are key to further narrow gender gap in life expectancy in Shanghai, China.

Authors:  Hanyi Chen; Yi Zhou; Lianghong Sun; Yichen Chen; Xiaobin Qu; Hua Chen; Janani Rajbhandari-Thapa; Shaotan Xiao
Journal:  BMC Public Health       Date:  2020-06-03       Impact factor: 3.295

Review 5.  Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond.

Authors:  Stephanie M Gruss; Kunthea Nhim; Edward Gregg; Miriam Bell; Elizabeth Luman; Ann Albright
Journal:  Curr Diab Rep       Date:  2019-08-05       Impact factor: 4.810

6.  A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort Study.

Authors:  Mojtaba Farjam; Hossein Bahrami; Ehsan Bahramali; Javad Jamshidi; Alireza Askari; Habibollah Zakeri; Reza Homayounfar; Hossein Poustchi; Reza Malekzadeh
Journal:  BMC Public Health       Date:  2016-10-18       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.